Publikationen, an denen er mitarbeitet Daniel Diez Iriepa (17)

2023

  1. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

    Acta Pharmaceutica Sinica B, Vol. 13, Núm. 5, pp. 2152-2175

2022

  1. Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment

    Antioxidants, Vol. 11, Núm. 9

  2. Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes

    Antioxidants, Vol. 11, Núm. 8

  3. Synthesis and Pharmacological Evaluation of New N-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout

    Journal of Medicinal Chemistry, Vol. 65, Núm. 8, pp. 6250-6260

2021

  1. Privileged quinolylnitrones for the combined therapy of ischemic stroke and alzheimer’s disease

    Pharmaceuticals, Vol. 14, Núm. 9

  2. Studies on the affinity of 6-[(: N -(cyclo)aminoalkyl)oxy]-4 H -chromen-4-ones for sigma 1/2 receptors

    RSC Medicinal Chemistry, Vol. 12, Núm. 6, pp. 1000-1004

  3. Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models

    Molecules (Basel, Switzerland), Vol. 26, Núm. 4

  4. Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments

    Chemical Record, Vol. 21, Núm. 1, pp. 162-174

2020

  1. Homo-tris-nitrones derived from α-phenyl-n-tert-butylnitrone: Synthesis, neuroprotection and antioxidant properties

    International Journal of Molecular Sciences, Vol. 21, Núm. 21, pp. 1-18

  2. Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models

    Scientific Reports, Vol. 10, Núm. 1

  3. Triazolopyridopyrimidine: A new scaffold for dual-target small molecules for Alzheimer's disease therapy

    Molecules, Vol. 25, Núm. 14

2019

  1. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489

  2. New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

    Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422

  3. Novel Quinolylnitrones Combining Neuroprotective and Antioxidant Properties

    ACS Chemical Neuroscience, Vol. 10, Núm. 6, pp. 2703-2706

  4. Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy

    Molecules, Vol. 24, Núm. 8

  5. Synthesis of (±)-cis-1-Aryl-3-oxo-2,3-dihydro-1H-benzo[f]chromene-2-carbonitriles and (±)-trans-4-Aryl-2-oxo-3,4-dihydro-2H-benzo[h]chromene-3-carbonitriles

    ChemistrySelect, Vol. 4, Núm. 44, pp. 12902-12905

  6. Synthesis, neuroprotective and antioxidant capacity of PBN-related indanonitrones

    Bioorganic Chemistry, Vol. 86, pp. 445-451